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Abstract
Raynaud’s phenomenon (RP) is often the first sign of systemic sclerosis (SSc).
Molecular mechanisms involved are incompletely understood, but reactive
oxygen, nitrogen, and sulfur species are thought to play an important role in
the pathogenesis of SSc. Free thiol groups play a protective role against oxida-
tive stress and may represent an attractive therapeutic target. We aimed to
investigate the effects of hypothermia-induced vasoconstriction on the respon-
siveness of redox-related markers. Thirty participants (n = 10/group [SSc, pri-
mary Raynaud’s phenomenon (PRP), healthy controls (HC)]) were included
in this study. Fingertip photoelectric plethysmography was performed during
a standardized cooling and recovery experiment. Venous blood was collected
at four predetermined time points. Free thiols, NO-derived species (nitros(yl)
ated species, nitrite, nitrate), sulfate and endothelin-1 were measured. Lower
baseline concentrations of free thiols were observed in PRP and SSc patients
(HC: 5.87 [5.41–5.99] lmol/g; PRP: 5.17 [4.74–5.61]; SSc 5.28 [4.75–5.80],
P = 0.04). Redox-related markers remained unchanged during cooling. How-
ever, an unexpected increase in systemic free thiol concentrations was
observed in all groups during the recovery phase. The response of this marker
differed between groups, with a higher increase found in SSc patients (HC
D = 1.30 [1.48–1.17]; PRP D = 1.04 [1.06–1.03]; SSc D = 1.72 [1.13–1.49],
P = 0.04). NO-derived species, sulfate and endothelin-1 levels remained
unchanged throughout the recovery phase. This exploratory study sheds light
on the rapid responsiveness of systemic free thiol concentrations following
reperfusion, which may reflect overall redox balance. The robust response to
reperfusion in SSc patients suggests that reductive systems involved in this
response are functionally intact in these patients.
ª 2019 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society.
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Introduction
Systemic sclerosis (SSc) is a complex connective tissue
disease of unknown etiology characterized by autoimmu-
nity and severe fibrosis in the skin and internal organs
(LeRoy and Medsger 2001; Denton and Khanna 2017).
Vasculopathy is the hallmark of this disease and associ-
ated with endothelial dysfunction, inflammation, and
extracellular matrix remodeling in the vascular wall. Ray-
naud’s phenomenon (RP), which is an episodic vasospas-
tic disorder of the extremities, is the earliest recognizable
clinical sign that reflects the vasculopathy in SSc (Herrick
2005). Patients with primary Raynaud’s phenomenon, in
the absence of an underlying systemic disease, lack these
(specific) vascular abnormalities. Increased levels of
endothelin-1 (ET-1), a potent vasoconstrictor, have
previously been reported in both SSc and PRP (primary
Raynaud’s phenomenon) patients (Zamora et al. 1990;
Mostmans et al. 2017). Due to the unavailability of effec-
tive therapy, these vascular abnormalities often lead to
severe morbidity and premature mortality (Leroy 1988;
Herrick et al. 2000; Matucci Cerinic and Kahaleh 2002).
Following Murrell’s hypothesis (Murrell 1993), stating
that the pathogenesis of SSc is linked to the generation of
reactive oxygen species (ROS), several studies have pre-
sented evidence that overproduction of ROS – a collective
term for oxygen-derived species with enhanced chemical
reactivity – plays an important role in the pathogenesis of
SSc (Herrick and Matucci 2001; Sambo et al. 2001;
Ogawa et al. 2006). Although chronically elevated levels
of ROS have been suspected to prolong disease, oxidative
stress (i.e., an imbalance between the production of ROS
and antioxidant defences (Jones and Sies 2015)) may also
be an initiating factor in the development of SSc vascu-
lopathy. In addition to the well-known damaging proper-
ties of ROS, other reactive species (i.e., reactive nitrogen
species [RNS] and reactive sulfur species [RSS]) are also
thought to play an important role in SSc (Matucci Ceri-
nic and Kahaleh 2002; Wang et al. 2016). More impor-
tantly, the chemical interactions between these reactive
species cause homeostatic disruption due to the produc-
tion of highly reactive free radicals and other secondary
metabolites (Nagpure and Bian 2016; Cortese-Krott et al.
2017). Therefore, these reactive species should be viewed
as a unified entity, also referred to as the “reactive species
interactome” (Cortese-Krott et al. 2017). In addition to
the increased production of free radicals, some have
shown that patients with SSc also exhibit a decreased level
of antioxidants, and enzyme activities related to the
defence against oxidative stress (Herrick and Matucci
2001; Ogawa et al. 2010). More particularly, endothelial
cells (ECs) were previously found to be catalase deficient
and, therefore, are more prone to ROS injury (Jornot and
Junod 1992). This deficiency may eventually initiate a
self-perpetuating cycle of recurrent RP attacks, increased
ROS production, ischemia/reperfusion (I/R) injury, and
an inability to defend against further stress.
Free thiol (i.e., sulfhydryl groups) are thought to play a
protective role against oxidative stress through ROS scav-
enging, and thereby function as sentinels of distant dan-
ger (Cortese-Krott et al. 2017). In addition, free thiols are
also believed to be part of an intricate network of the
redox system which regulates crucial roles in proteins,
and may lead to adjustment of protein structures and
enzymatic functions according to the redox state (Go
and Jones 2011). Free thiols can be oxidized by ROS and
other reactive species, and are active components of
antioxidant buffer capacity, implicating that their extra-
cellular level may be a direct reflection of overall redox
status (Banne et al. 2003; Chung et al. 2013; Turell et al.
2013; Cortese-Krott et al. 2017). Therefore, chronic sys-
temic oxidative stress can simply be measured as the
depletion of the free thiols in serum, which mainly con-
sists of the single free SH-group of human serum albumin
(Banne et al. 2003). Several studies have previously
demonstrated clear evidence that free thiols are an indi-
rect measure of systemic oxidative stress. For instance, in
I/R related disorders such as myocardial stunning,
researcher have previously shown a loss of sulfhydryl
groups following I/R. Moreover, in other conditions (e.g.,
chronic heart failure and renal transplantation) thiol
depletion predicted mortality and disease outcome and
was associated with cardiovascular disease (Koning et al.
2015, 2016).
A better understanding of the role played by oxidative
stress during a Raynaud’s attack could help to identify
early interventions aimed at delaying the onset of overt
symptoms and/or attenuating the course of the disease.
The aim of this exploratory study was threefold. First,
we sought to investigate whether redox-related makers
(free thiols, NO-derived species and sulfate [stable end
product of hydrogen sulfide]) measured at baseline differ
between groups. Second, we wanted to assess the differ-
ence in effects of hypothermia induced vasoconstriction
on the responsiveness, as defined as the change (delta)
during cooling and recovery, of redox related markers
between SSc patients, PRP patients and healthy controls
(HC). Lastly, we aimed to investigate whether there is an
association between the deltas of these markers. We
hypothesized that a lower steady-state concentration of
free thiols would be observed in patients with SSc, due
to the chronic inflammation and impaired antioxidative
defence mechanism. In addition, we anticipated to find a
difference in response to recovery in comparison to the
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initial vasospastic event, due to the assumption that




This study was conducted in accordance with the Declara-
tion of Helsinki. Study approval was obtained from the
local Medical Ethics Committee of the University Medical
Centre Groningen (METc 2015/219), the Netherlands,
and all participants provided written informed consent.
This study was registered in the research database of the
UMCG (NL53132.042.15).
Patient population
This exploratory study was conducted between 2015 and
2016 at the University Medical Centre Groningen (the
Netherlands). Three groups of participants all aged
≥18 years were included, group 1 comprised of healthy
controls without a history of RP (N = 10), group 2
included patients with PRP (N = 10), and group 3 com-
posed of patients with RP secondary to SSc (N = 10). All
SSc patients fulfilled the American College of Rheumatol-
ogy/European League Against Rheumatism (ACR/EULAR)
2013 criteria (Van Den Hoogen et al. 2013). PRP patients
had negative serology, normal nailfold capillaries assessed
with capillaroscopy and no clinical history of digital
ulcers. Diagnosis of PRP was confirmed by the treating
physician. Subjects were excluded in case of inaccessibility
of the photoelectric plethysmograhy (PPG) measure-
ments.
Photoelectric plethysmography of the
fingers during cooling and recovery
A standardized cooling and recovery experiment was per-
formed (Fig. 1) and concomitantly PPG was recorded as
described previously (Wouda 1977; Suichies et al. 1992;
van Roon et al. 2016). All subjects were asked to refrain
from alcohol intake and smoking at least 8 h before the
assessments. Before the measurements, patients were
allowed to acclimatize for half an hour in a room with a
stable temperature of 23–24°C. During the experiment,
the left hand of the subject (to the level of the radio-
carpal joint) was submerged in a water bath of 33°C
with PPG sensors attached to each finger, enabling
simultaneous measurement of perfusion in all five digits.
Water was cooled every 4 min by 3°C, for 36 min in
total, with water at 6°C at the end of cooling. During
each step, there was a stabilization period of 4 min for
each temperature, after which 15 sec of perfusion was
recorded. In case of unendurable pain the cooling exper-
iment was discontinued and that time was marked as
time point 1 (T1). After the cooling steps, the hand was
taken out of the water, padded dry and then rested on a
dry towel to track recovery of perfusion in the open air
for 10 min (time point 2). Perfusion was recorded dur-
ing the last 15 sec of every minute during recovery.
Mean ischemic time (minutes) was calculated for all fin-
gers and was defined as the mean time of perfusion loss
during cooling and recovery. PPG pulses were analyzed
from R-peak (detected in the ECG) up to 600 msec. The
mean (SD) of the amplitude of the pulses was deter-
mined, and a signal-to-noise ratio (S/N) was calculated.
Perfusion was defined as S/N > 15 (van Roon et al.
2016). The experiment was deemed positive for RP when
≥2 fingers lost perfusion and stayed abnormal during ≥2
consecutive steps. Data acquisition was performed using
a Biopac MP-100 system with five PPG100C amplifiers
and PPG200C sensors (infrared light, 860 nm), an
ECG100C amplifier with ECG-cables, an SKT100C
amplifier and TSD202C temperature sensor, and
AcqKnowledge 3.8.2 software (Biopac Systems Inc.,
Goleta, CA). All signals (ECG, temperature and 5 PPG’s)
are sampled at 100 Hz and stored in a file for off-line
processing with dedicated software to determine pulsa-
tions in each finger.
Clinical and laboratory assessments
The following patient characteristics were obtained: sex,
age, smoking behavior, comorbidities, body weight (kg),
length (cm), and use of medication. Furthermore, the
presence of digital ulcers (DU) was documented and clin-
ical evaluations including serum autoantibodies profile,
esophageal scintigraphy and pulmonary function tests
were performed in all SSc patients.
Blood was drawn from the antecubital vein of the left
arm at four time points: at baseline (T0), at the end of
the cooling experiment (T1), and 10 min (T2) and
30 min (T3) after start of recovery. Plasma and serum
samples were stored at 80°C and thawed just before
use. Prior to storing, samples were centrifuged at 1300 g
at room temperature for 10 min. Markers of oxidative
stress (free thiols), NO-derived species and sulfate were
measured. Nitros(yl)ated species (RXNO), nitrite, nitrate,
and free thiols (corrected for proteins) were analyzed by
gas-phase chemiluminescence and ion chromatography as
previously described (Feelisch et al. 2002; Rassaf et al.
2002; Koning et al. 2016). Serum levels of ET-1 were
measured according to the manufacturer’s instructions
using commercially available Quantikine ELISA kits
(DET10 R&D Systems, Abingdon, UK) as previously
ª 2019 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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described (Jongman et al. 2014). Plasma sulfate was mea-
sured by ion chromatography, as described earlier (Kon-
ing et al. 2017).
Statistical analysis
Statistics were performed with The Statistical Product
and Service Solutions (SPSS; version 22, Released 2013,
IBM Corp., Armonk, NY). The data of this pilot study
are presented as mean  standard deviation for nor-
mally-distributed data and median (interquartile range)
for data that was nonnormally distributed. Given the
design of the study, the experiment was analyzed in two
parts: from time point 0 to time point 1 (cooling) and
from time point 1 to time point 3 (recovery). Differ-
ences between groups at baseline were analyzed using
nonparametric test (Kruskal–Wallis, Mann–Whitney U).
The main objective (difference in responsiveness of the
markers between groups during cooling and recovery as
measured by the delta) was assessed using paired non-
parametric test (Wilcoxon signed-rank test). In addition,
correlations between the calculated deltas of the markers
during cooling and mean ischemic time during cooling
were determined by either Pearson or Spearman correla-
tion coefficients. In addition, we also assessed the associ-
ation between the calculated deltas of the markers
during recovery and mean ischemic time during recov-




In total, 32 subjects were found eligible to participate in
the study. Two subjects were excluded due to an inacces-
sible PPG measurement, thus 30 subjects were included
in the analysis. Characteristics of the study participants
are displayed in Table 1. The median age of all subjects
was 43 years (range 18–73) and 20 (HC n = 7, PRP
n = 8, SSc n = 5) of them were females. Raynaud’s attack
was successfully induced in all PRP and SSc patients, but
not in the healthy controls. Three PRP patients and 7 SSc
patients prematurely ended the cooling part of the experi-
ment due to unendurable pain. Time at which unen-
durable pain had occurred was marked as time point 1
(end of cooling).
Digital perfusion during standardized
cooling and recovery experiment
The percentage of digits with normal perfusion assessed
with PPG during the cooling and recovery experiment is
depicted in Figure 2. A longer duration of mean ischemic
time was observed in SSc patients (30 min, 24–37 min)
compared to PRP (12 min, 9–14 min, P = 0.01) and HC
(1,1 min, 0–3.7 min, P < 0.001). Also, a considerably
longer recovery time was found in the SSc group com-
pared to the PRP group (SSc: 8 min [4–10 min]; PRP:
1.1 min [1.0–2.1 min], P < 0.001), and about 50% of the
baseline perfusion recovered 10 min after cessation of
cooling stress in SSc patients.
Baseline comparison of circulating
biomarkers
Baseline median levels of free thiols for the groups are
illustrated in Figure 3. Significantly lower concentrations
of total free thiols, indicating higher oxidative stress, were
observed in PRP and SSc patients, compared to healthy
controls (HC: 5.87 [5.41–5.99] lmol/g; PRP: 5.17 [4.74–
5.61] lmol/g protein; SSc 5.28 [4.75–5.80] lmol/g pro-
tein, P = 0.04). No significant differences between PRP
and SSc were observed (P = 0.59). Although nitrate, sul-
fate and ET-1 tended to be higher in SSc patients, no sig-
nificant differences between groups were observed in
Figure 1. Schematic overview of the study experiment. “Cooling” refers to a temperature ramp between 33°C and 6°C implemented over
36 min.
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baseline levels of NO-derived species (nitrate: P = 0.23;
nitrite: P = 0.88; RXNO: P = 0.88, Fig. 4), ET-1
(P = 0.24, Fig. 5) and sulfate (P = 0.14, Fig. 6).
Differences in responsiveness of the
markers between groups during cooling
(time point 0 to time point 1) and during
recovery (time point 1 to time point 3)
During cooling, free thiols, NO-derived species, sulfate,
and ET-1 remained unchanged. As shown in Figures 3–5,
the deltas of free thiols, NO-derived species, and ET-1
were comparable between groups (free thiols P = 0.27;
nitrate P = 0.64; nitrite P = 0.99; RXNO P = 0.48, ET-1
P = 0.77). In contrast, circulating sulfate concentrations
were significantly different between groups, and the high-
est delta was observed in the healthy controls (P = 0.03,
Fig. 6).
During the recovery phase, we found that free thiol
concentrations not only recover during reperfusion, but
reach levels that exceed baseline concentrations. This find-
ing was coincided with stable concentrations of the gaso-
transmitter end-products nitrite and nitrate (in part,
originating from NO) and sulfate (related to H2S). More-
over, the delta of free thiol concentrations was signifi-
cantly different between groups (Fig. 3, P = 0.04).
However, those of the NO-derived species, ET-1, and sul-
fate were comparable between groups (nitrate P = 0.68;
nitrite P = 0.89; RXNO P = 0.06; sulfate P = 0.31; ET-1
P = 0.25).
Correlations between laboratory markers
and mean ischemic time during cooling and
recovery
We investigated the correlation between the delta of these
markers and mean ischemic time during cooling and
recovery, but found no significant correlations. Further-
more, correlations between the markers were assessed
during cooling and recovery. During cooling, we observed
a positive correlation between delta nitrate and nitrite
(r = 0.54, P < 0.01), delta sulfate and nitrite (r = 0.39,
P = 0.03) and delta sulfate and free thiols (r = 0.48,
P < 0.01). During recovery, only the positive correlation
between delta nitrate and nitrite was found to be signifi-
cant (r = 0.44, P = 0.02).







Age (years), mean  SD 29.9  2.7 47.8  16.2 56.2  11.5
Female gender, n 7 8 5
Weight (kg), mean  SD 71.3  11.7 64.4  11.9 73.3  11.3
Height (cm), mean  SD 177  8.7 170  10.0 176  5.9
Smoking, n
Current 0 1 2
Past smoker 0 3 7
Comorbidities, n
Hypertension 0 1 2
Hypercholesterolemia 0 0 1
Diabetes 0 1 0
ACR/EULAR score ≥9, n 0 0 10
Disease duration (years), median (IQR) N/A 8.0 (4.0-17.0) 4.5 (3.0-6.3)
Abnormal NCM pattern, n 0 0 10
Positive autoantibodies, n 0 0 8
Organ involvement, n
Pulmonal 0 0 0
Esophageal 0 0 3
Creatinine, median (IQR) 72.1 [66.5-77.6] 72.0 [63.5-72.0] 76.2 [63.5-88.6]
eGFR, median (IQR) 94.5 [90.6-114.8] 79.3 [68.3-97.4] 86.6 [74.1-98.5]
Digital ulcers, n 0 0 6
Medication, n
Nifedipine 0 1 2
Iloprost 0 0 2
Bosentan 0 0 3
ACR/EULAR, The American College of Rheumatology/European League Against Rheumatism (EULAR); NCM, Nailfold Capillary Microscopy.
ª 2019 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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Discussion
This pilot study demonstrated that circulating free thiol
concentrations are lower at baseline in PRP and SSc
patients compared to HC. Moreover, we observed a rapid
increase in free thiols in all groups during recovery fol-
lowing transient hypothermia. Our findings coincided
with stable concentrations of the gasotransmitter end-pro-
ducts nitrite and nitrate (in part, originating from NO)
and sulfate (related to H2S). These results not only sug-
gest that RP patients (i.e., primary and secondary) have
chronically increased levels of oxidative stress, but also
indicate that free thiol concentrations are rapidly elevated
following transient hypothermia-induced vasoconstriction.
The latter was an unexpected finding that warrants fur-
ther investigation.
Raynaud’s phenomenon in SSc patients often precedes
the onset of other symptoms (e.g., organ involvement) by
several years. Although primary and secondary RP share
some similarities from a pathophysiological point of view,
secondary RP is more likely to be associated with severe
complications of vascular insufficiency due to endothelial
abnormalities (Houtman et al. 1985; Herrick 2005, 2012,
2017; Flavahan 2015). In support, the potent vasocon-
strictor ET-1 was previously suggested to play an impor-
tant role in the pathogenesis of SSc vasculopathy (Silveri
et al. 2001; Avouac et al. 2013; Mostmans et al. 2017).
Although we did observe higher concentration of ET-1 in
SSc patients, this marker remained stably elevated
throughout the experiment. This finding is in accordance
with a previous study conducted by Smyth and colleagues
(2000) who did not find clear differences during a cooling
experiment. Collectively, these findings suggest that ET-1
is not involved in changes in vascular tone during tran-
sient hypothermia.
This study showed a significantly lower baseline level of
free thiols in both PRP and SSc patients as compared to
HC, which may be indicative of chronically increased
levels of oxidative stress. Oxidative stress arises when the
production of ROS outweighs the buffering capacity of
antioxidant defences, eventually leading to cellular dam-
age (Jones and Sies 2015). Following oxidation, serum
Figure 2. Digital perfusion during cooling and recovery experiment. Percentage of digits with normal perfusion (95% CI) assessed with
photoelectric plethysmography during stepwise cooling and recovery. Lines represent healthy controls (n = 10), patients with primary Raynaud
(n = 10) and SSc patients (n = 10). The vertical dashed line indicates the beginning of the recovery phase. All healthy controls completed the
entire cooling duration of 36 min. Seven primary Raynaud patients completed the cooling experiment, two patients discontinued after 32 min
(9°C), and one patient discontinued after 12 min (24°C). In addition, three systemic sclerosis patients completed the cooling experiment, one
patient discontinued after 20 min (18°C), one patients discontinued after 24 min (15°C), two patients discontinued after 28 min (12°C), and
three patients discontinued after 32 min (9°C). In addition to the cooling phase, perfusion of all participants was measured during the recovery
phase. HC, healthy controls; PRP, primary Raynaud’s phenomenon; SSc, systemic sclerosis.
2019 | Vol. 7 | Iss. 6 | e14017
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thiols are not easily reduced compared to their intracellu-
lar counterparts, indicating that they are a relatively stable
reflection of the systemic redox status. Consistent with
this assumption, a marked reduction in serum protein
thiols was previously observed in active SSc (Lau et al.
1992; Banne et al. 2003; Giovannetti et al. 2012). This dif-
ference could also be explained by the difference in smok-
ing behavior between the groups. For instance, a current
hypothesis is that the damaging properties of smoking
can even occur after cessation of smoking. Therefore, SSc
patients may experience prolonged oxidative-stress
induced damage even after cessation of smoking.
Interestingly, our analyses revealed an additional unex-
pected biomarker feature, that is, a significant increase in
concentration of free thiols during the recovery phase in
all groups. Specifically, we here demonstrate that free
thiol concentrations not only recover during reperfusion,
but reach levels that exceed baseline concentrations. This
increase in free thiols (we here define as “thiol rebound”)
could be explained by several mechanisms. First, our find-
ings may be the result of rapid reversibility and dynamic
nature of processes related to oxidative thiol modification,
which lowers the availability of total free thiols (reduced
thiols) in the circulation. In a previously conducted
experimental study in mice, the protective mechanism in
endothelial function following I/R of thioredoxin, a disul-
fide-reducing protein, was shown (Subramani et al.
2016). A similar mechanism could also play a role in
hypothermia induced Raynaud’s attack. Secondly, this
rapid responsiveness of free thiols may be the result of a
physiological acute response to reperfusion, which may
alter the oxidative balance. This hypothesis is supported
by the fact that this thiol rebound phenomenon was also
observed in healthy controls. Third, as overall thiol redox
status is presumably affected by NO-derived species (Cor-
tese-Krott et al. 2017), it is conceivable that NO plays an
important role in the processes related to thiol modifica-
tion, that could have led to the previously mentioned
thiol rebound. However, we have to address the fact that
no significant increase in nitrate, or any other NO-deriva-
tive measured was observed in healthy controls and PRP
patients, despite the presence of the thiol rebound during
reperfusion. This observation may indicate that free thiols
can be produced/modified independently of NO-derived
species.
Hydrogen sulfide (H2S), which is one of the three main
gasotransmitters, has been reported to have vasodilator
and antioxidant capacity. Therefore, a current hypothesis
is that H2S may play a more prominent role in the devel-
opment SSc vasculopathy. In this study we investigated
the effect of hypothermia on plasma concentrations of
sulfate, which is a stable end product of H2S. We
observed a trend in elevated plasma levels of sulfate in
SSc patients throughout the entire experiment. Urinary
Figure 3. Median (IQR) concentration of free thiols during cooling (A) and recovery (B). Measurements at four different time points during a
standardized cooling and recovery experiment in healthy controls (n = 10 at all time points), primary Raynaud (n = 10 during cooling,
n = 910 min after start recovery and n = 8 at the end of recovery) and systemic sclerosis patients (n = 10 during cooling and 10 min after
start recovery, n = 9 at the end of recovery). The asterisk represents a significant difference between groups (P < 0.05). During cooling: HC
D = 0.48 [0.57 to 0.29], PRPD = 0.09 [0.29–0.11], SSc D = 0.48 [0.38 to 0.41]. During recovery: HC D = 1.30 [1.48–1.17]; PRP
D = 1.04 [1.06–1.03]; SSc D = 1.72 [1.13–1.49].
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sulfur metabolites, such as sulfate, were previously found
to be associated with renal function, favorable cardiovas-
cular risk profile and an improved survival in renal trans-
plant recipients (van den Berg et al. 2014) However, as
none of the participants had an impaired kidney function
our findings are unlikely explained by disturbances in
kidney function. In addition, as we also observed a trend
towards increased levels of both nitrate and sulfate in SSc
patients, it is plausible that these markers of the redox
system interact with one another through the same path-
way; underlining the complexity of the redox interactome.
The fact that both chemical compounds are known diet-
ary constituents complicates the interpretation of these
results inasmuch as we cannot exclude that differences in
the consumption of nitrate and sulfate containing nutri-
ents may have contributed to the observed changes. Clari-
fication of the interaction of these signaling molecules in
the pathogenesis of PRP and SSc awaits further studies.
The exploratory study has some limitations. First, it
could be argued that that the aging process (i.e., older
age) itself potentially influences the level of oxidative
stress. For instance, several studies have shown that age-
ing cells accumulate increased levels of oxidant-damaged
DNA, which may further increase the level of oxidative
stress. Therefore, the large age-range could potentially
affect the baseline level of free thiols. Despite this differ-
ence in age between the groups, we have demonstrated
that all three groups show the “thiol rebound” phe-
nomenon. This finding may suggest that the response of
free thiol level following hypothermia induced vasocon-
striction, is not influenced by age. However, in order to
investigate the effect of age on the redox status large age-
matched control-group has to be included. Second, we
acknowledge the fact that the differences in gender
between groups may play an important role in the oxida-
tive balance. Given the small number of males included
Figure 5. Median (and IQR) concentration of endothelin-1 during cooling (A) and recovery (B). Measurements at four different time points
during a standardized cooling and recovery experiment in healthy controls (n = 10 at all time points), primary Raynaud (n = 10 during cooling,
n = 910 min after start recovery and n = 8 at the end of recovery) and systemic sclerosis patients (n = 10 during cooling and 10 min after
start recovery, n = 9 at the end of recovery). During cooling: HC: D = 0.18 [0.25 to 0.26]; PRP: D = 0.37 [0.28 to 0.31]; SSc:
D = 0.56 [0.34 to 0.86]. During recovery: HC D = 0.33 [0.05–0.84]; PRP D = 0.79 [0.64–1.02]; SSc D = 0.64 [0.52–3.63].
Figure 4. Median (IQR) concentration of NO-derived species (nitrite, nitrate and RXNO) during cooling (A) and recovery (B). Measurements at
four different time points during a standardized cooling and recovery experiment in healthy controls (n = 10 at all time points), primary
Raynaud patients (n = 10 during cooling, n = 9 10 min after start recovery and n = 8 at the end of recovery) and systemic sclerosis patients
(n = 10 during cooling and 10 min after start recovery, n = 9 at the end of recovery). During cooling: HC: nitrate: D = 0.28 [0.53–4.04],
nitrite: D = 0.01 [0.03–0.008], RXNO: D = 6.32 [3.65–4.56]; PRP: nitrate: D = 0.09 [0.31–6.57], nitrite: D = 0.03 [0.0004–0.04], RXNO:
D = 0.84 [1.16–4.09]; SSc: nitrate: D = 5.65 [6.03 to 9.17], nitrite: D = 0.03 [0.01–0.004], RXNO: D = 3.88 [3.72–3.24]. During recovery:
HC: nitrate D = 6.34 [0.18 to 2.99], nitrite D = 0.05 [0.03 to 0.04], RXNO D = 2.74 [2.80 to 4.38]; PRP: nitrate D = 0.29 [1.07 to
5.89], nitrite D = 0.03 [0.001 to 0.03], RXNO D = 2.30 [4.22–5.61]; SSc nitrate D = 7.01 [8.83 to 8.71], nitrite D = 0.007 [0.02–
0.02], RXNO D = 0.98 [1.88 to 0.18].
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in this study, we were unable to demonstrate gender dif-
ferences. However, this information could give us valuable
insight that could potentially clarify the complexity of the
redox system, and, therefore, future studies should inves-
tigate these gender differences. Third, other factors such
as blood pressure, cholesterol and co-morbidities were
not assessed in this study. However, given the fact that
the majority of the participants, did not show signs of
hypertension or hypercholesterolemia 1 year prior and/or
1 year after the experiment (as assessed by the caregiving
rheumatologist or internist), it would be unlikely that the
inclusion of these factors would influence our result.
Fourth, patients were not asked to discontinue their med-
ication. As many of the vasoactive medication may alter
the oxidative balance, it is possible that that the “thiol
rebound” phenomenon as observed in SSc patients could
potentially be even higher. Fifth, due to the small sample
size it was not feasible to analyze differences between SSc
patients with reperfusion and those with prolonged ische-
mia. However, based on the results of this study it is pos-
sible to calculate effect sizes, and this will assist future
studies in their sample size calculation. Sixth, some
patients did not complete the cooling experiment because
of unendurable pain and objective documentation of the
development of ischemia was lacking in these patients.
However, the majority of these patients were SSc patients,
and no one in the healthy control group prematurely dis-
continued the experiment. It is therefore conceivable that
these SSc patients prematurely discontinued the experi-
ment due to an RP attack. Despite these limitations, we
were able to demonstrate clear differences in the levels of
circulating free thiols during the course of a unique cool-
ing and recovery experiment.
In conclusion, this study demonstrates decreased circu-
lating free thiol concentrations in primary RP and SSc
patients as compared to healthy controls. Moreover, an
unexpected rapid increase in free thiols was present in all
individuals during the reperfusion phase of the standard-
ized cooling experiment. The rapid responsiveness of this
redox related marker demonstrates the dynamic nature of
this seemingly simple biomarker and may be the result of
a physiological acute response to reperfusion, which may
alter the oxidative balance. The observed response to
reperfusion in SSc patients suggests that systems involved
in the thiol responsiveness are functionally intact in these
patients. Whether a further enhancement of this response,
through therapeutic intervention, confers additional pro-
tection in SSc and RP remains to be investigated.
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